Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications

BACKGROUND: HER-2/neu and c-kit (CD117) onco-protein are increasingly being recognized as targets for therapy in solid tumors, but data on their role in malignant melanoma is currently limited. We studied the prevalence of overexpression of HER-2/neu and c-Kit in 202 patients with malignant melanoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Potti, Anil, Hille, Rachel C, Koch, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC280698/
https://www.ncbi.nlm.nih.gov/pubmed/14617373
http://dx.doi.org/10.1186/1477-3163-2-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC280698/
https://www.ncbi.nlm.nih.gov/pubmed/14617373
http://dx.doi.org/10.1186/1477-3163-2-8

Ejemplares similares